Tag: glioblastoma

DJ utilized the innovative Tumor-Treating Fields technology by wearing the Optune device for 2 years. Last year, DJ joined the Head for the Cure staff as its Community Outreach Coordinator.

For the first time in 12 years, glioblastoma patients in Canada have a new treatment option.

Lynn was living a fast-paced life before she was diagnosed with glioblastoma (GBM). Since her diagnosis, she’s shifted her perspective and found renewed peace and positivity through her unshakeable bonds with friends and family. Making Time for Too Much I used to be a hardworking, never tired, work-till-I-dropped kind of person. Ever heard of that pink bunny character, the one who sells batteries? Well, let’s just say, my energy could’ve put that guy to shame.  I used to leave for work at 5:30 a.m. and return home around 7:15 p.m. On Monday nights, I would dance …

A brain tumor patient will encounter numerous specialists and need to make a multitude of decisions throughout their journey. With these factors and more, navigating cancer care can be overwhelming.  For patients with glioblastoma (GBM), management is even more challenging due to their poor prognosis, feelings of isolation, need for treatment, and cognitive decline associated with this rare and progressive disorder. For these reasons, shared decision-making (SDM) must be integrated into standard practice so that patients’ expectations and goals are considered when discussing and weighing the risks and benefits of treatments.

The Ivy Brain Tumor Center at Barrow Neurological Institute and SonALAsense announced positive results in their first-in-human Phase 0/1 clinical trial of SDT in recurrent glioblastoma patients. The initial results were presented at the European Society for Medical Oncology Congress today by Nader Sanai, MD, Director of the Ivy Brain Tumor Center. “The Ivy Center’s Phase 0/1 study has shown a promising translation of the preclinical results of SDT in patients with glioblastoma.

Today, July 21st, marks the 3rd Annual Glioblastoma (GBM) Awareness Day. Brains for the Cure invites you to join us, Head for the Cure, and the entire brain tumor community on honoring this important day! …

Dr. Nick Avgeropoulos, Orlando Health – UF Cancer Center, is confident that in many clinical trials a treatment was found that could work, however, they may not have been the exact right dose or for …

In a global clinical trial, GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment), Henry Ford Cancer Institute is the first to activate two new treatments for glioblastoma. The GBM AGILE trial allows for global collaboration …

Greg reflects as he readies for his routine 3-month MRI. His new passion is helping others who are living with a brain tumor to provide guidance and hope.

Novocure and GT Medical Technologies continue to move forward and make progress in their research to creating a better quality of life for patients and improving survival rates.